Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Warrell

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reports|July 1, 1986
Limited activity of carboplatin in malignant lymphomaL Danieu, R P Warrell
Important Advances in Oncology|January 1, 1989
Gallium in the treatment of hypercalcemia and bone metastasisR P Warrell, R S Bockman
Cancer|October 1, 1994
Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studiesM A Weiss, R P Warrell
American Journal of Clinical Oncology|February 1, 1983
Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphomaR P Warrell, S J Kempin
Current Oncology Reports|December 21, 2000
Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemiaE M Calleja, R P Warrell
Lancet (London, England)|August 7, 1993
Recovery from extreme hypercalcaemiaR P Warrell, J P Crown
The New England Journal of Medicine|August 1, 1985
Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitateR P Warrell, S J Kempin
Seminars in Oncology|October 26, 2000
Arsenicals in hematologic cancersS C Novick, R P Warrell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1983
Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospectsR P Warrell, J H Burchenal
Leukemia|June 1, 1994
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemiaA M Eardley, G Heller, R P Warrell
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reports|July 1, 1986
Limited activity of carboplatin in malignant lymphomaL Danieu, R P Warrell
Important Advances in Oncology|January 1, 1989
Gallium in the treatment of hypercalcemia and bone metastasisR P Warrell, R S Bockman
Cancer|October 1, 1994
Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studiesM A Weiss, R P Warrell
American Journal of Clinical Oncology|February 1, 1983
Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphomaR P Warrell, S J Kempin
Current Oncology Reports|December 21, 2000
Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemiaE M Calleja, R P Warrell
Lancet (London, England)|August 7, 1993
Recovery from extreme hypercalcaemiaR P Warrell, J P Crown
The New England Journal of Medicine|August 1, 1985
Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitateR P Warrell, S J Kempin
Seminars in Oncology|October 26, 2000
Arsenicals in hematologic cancersS C Novick, R P Warrell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1983
Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospectsR P Warrell, J H Burchenal
Leukemia|June 1, 1994
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemiaA M Eardley, G Heller, R P Warrell
Pageof 12